Injectable Self-Harden Antibiofilm Bioceramic Cement for Minimally Invasive Surgery

ACS Biomater Sci Eng. 2023 Nov 13;9(11):6225-6240. doi: 10.1021/acsbiomaterials.3c00822. Epub 2023 Oct 31.

Abstract

There is an urgent demand for antibacterial bone grafts in clinics. Worryingly, the misuse and overuse of antibiotics accelerate the emergence of drug-resistant bacteria. Therefore, this study prepared a novel injectable bioceramic cement without antibiotics (FS-BCS), which showed good antibacterial properties by loading iron and strontium onto a matrix composed of brushite and calcium sulfate. The setting time, injectability, microstructure, antibacterial properties, anti-biofilm properties, and cytocompatibility of the novel bioceramic cement were evaluated thoroughly. The results showed that the material was highly injectable and antiwashout. The antibacterial tests revealed that FS-BCS inhibited the growth of 99.9% E. coli and S. aureus separately in the broth due to the synergistic effect of strontium and iron. Simultaneously, crystal violet and fluorescent staining tests revealed that the material could significantly inhibit the formation of E. coli and S. aureus biofilms. In addition, the co-incorporation of iron and strontium promoted the proliferation and migration of osteoblasts. Therefore, FS-BCS has good application potential in antibiotic-free anti-infection bone grafting using minimally invasive surgery.

Keywords: anti-biofilm; antibacterial properties; bone cement; injectable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Bone Cements / chemistry
  • Bone Cements / pharmacology
  • Escherichia coli*
  • Iron / pharmacology
  • Minimally Invasive Surgical Procedures
  • Staphylococcus aureus*
  • Strontium / pharmacology

Substances

  • Bone Cements
  • Anti-Bacterial Agents
  • Iron
  • Strontium